Valeant Pharmaceuticals International
4 activist/short documents on this target.
Timeline
2015-05-01
Pershing Square · full deck
Traditional P/E ignores Valeant's 'Platform Value' from disciplined M&A capital allocation
N4 V3
2015-05-04
Pershing Square · conference presentation
Platform companies are undervalued because P/E ignores value from future acquisitions
N5 V4
2015-10-30
Pershing Square · conference presentation
Citron's 'next Enron' channel-stuffing claim is verifiably false; Philidor accounting is conservative
N5 V3
2015-10-30
Pershing Square · full deck
Citron's 'next Enron' channel-stuffing claim is verifiably false; Philidor accounting is conservative
N4 V3